Berenberg Bank Reiterates €88.10 Price Target for Fresenius SE & Co KGaA (FRE)

Berenberg Bank set a €88.10 ($108.77) price objective on Fresenius SE & Co KGaA (FRA:FRE) in a research report report published on Monday. The brokerage currently has a buy rating on the stock.

A number of other equities analysts have also recently issued reports on FRE. UBS set a €59.00 ($72.84) target price on Fresenius SE & Co KGaA and gave the stock a sell rating in a report on Wednesday, April 11th. Warburg Research set a €80.00 ($98.77) target price on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Thursday, February 8th. Independent Research set a €80.00 ($98.77) target price on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Thursday, January 4th. Barclays set a €81.00 ($100.00) target price on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Friday, February 2nd. Finally, Citigroup set a €83.00 ($102.47) target price on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Monday, February 12th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. The stock currently has an average rating of Buy and a consensus target price of €77.69 ($95.91).

How to Become a New Pot Stock Millionaire

Shares of FRA FRE opened at €65.96 ($81.43) on Monday. Fresenius SE & Co KGaA has a 12 month low of €60.16 ($74.27) and a 12 month high of €80.00 ($98.77).



TRADEMARK VIOLATION NOTICE: “Berenberg Bank Reiterates €88.10 Price Target for Fresenius SE & Co KGaA (FRE)” was first reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://stocknewstimes.com/2018/04/20/berenberg-bank-reiterates-88-10-price-target-for-fresenius-se-co-kgaa-fre.html.

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply